Olanzapine Tablet, Orally Disintegrating
Product Images NDC 60505-3278

9 FDA label images from Apotex Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 60505-3278). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg Bottle 30s

10mg Bottle 30s
Label for Olanzapine 10 mg orally disintegrating tablets, USP, containing 30 tablets per container. The label includes storage instructions, manufacturer information (Apotex Inc., Canada), and labeler (Apotex Corp., Florida). It features a yellow and green design with black text and a barcode.*
FDA Label Image

10mg Carton

10mg Carton
Packaging label for Olanzapine Orally Disintegrating Tablets, USP 10 mg by Apotex Corp. The label includes the product name, dosage form, strength, and manufacturer. It indicates the package contains 100 tablets (10 x 10 blister cards) with a prescription use only statement. Storage instructions, NDC 60505-3276-0, and a medication guide website are also visible on the label.*
FDA Label Image

15mg Bottle 30s

15mg Bottle 30s
Label for Olanzapine Orally Disintegrating Tablets, USP, 15 mg strength, in a 30 tablet container. The label indicates storage instructions, manufacturer Apotex Corp., and dispensing information including a website for medication guides. The product is identified by NDC 60505-3277-3.*
FDA Label Image

15mg Carton

15mg Carton
Packaging label for Olanzapine Orally Disintegrating Tablets, USP 15 mg, distributed by Apotex Corp. The label shows a carton layout including branding, strength, dosage form, and the quantity of 100 tablets (10 tablets per unit dose). The NDC code 60505-3277-0 and storage instructions are also visible.*
FDA Label Image

20mg Bottle 30s

20mg Bottle 30s
Label for Olanzapine Orally Disintegrating Tablets, USP 20 mg, in a 30-tablet package. Manufactured by Apotex Inc. and labeled for Apotex Corp., the label includes storage instructions, dosage form, strength, and a barcode. It also notes to dispense with the medication guide from Apotex's website.*
FDA Label Image

20mg Carton

20mg Carton
Packaging label for Olanzapine orally disintegrating tablets, USP, 20 mg strength. The carton design features the product name prominently with dosage form and strength details. It is labeled as a prescription drug by Apotex Corp. The label includes regulatory and barcode information.*
FDA Label Image

5mg-100s-carton.jpg (5mg 100s Carton)

5mg-100s-carton.jpg (5mg 100s Carton)
Packaging label for Olanzapine Orally Disintegrating Tablets, USP, 5 mg strength, from Apotex Corp. The label indicates a package of 100 tablets (10 x 10 unit doses). It includes dosage form, strength, manufacturer details, NDC 60505-3275-0, barcode, and regulatory information. The label is primarily blue and yellow with clear dosing and manufacturer identification.*
FDA Label Image

5mg Bottle 30s

5mg Bottle 30s
Label for Olanzapine Orally Disintegrating Tablets, USP, 5 mg strength, with a package quantity of 30 tablets. The label includes storage instructions, dosage information, and notes the product is manufactured by Apotex Inc. and labeled by Apotex Corp. The label features a barcode and the NDC 60505-3275-3.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of olanzapine, showing the molecular arrangement of atoms including nitrogen, sulfur, and methyl groups as part of its ring systems.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.